speb/financial-data huggingface dataset:
Financial ratios for QLYS — quarterly report dated 2025-09-30
Total revenue: 169882000
Gross profit: 142084000
Operating income: 59955000
Net income: 50346000
Capital expenditures: 901000
Operating cash flow: 90382000
Depreciation & amortization: 3198000
Net tangible assets: 517062000
Owner earnings: 52643000
Return on net tangible assets (%): 10.181177499023327
Capex to operating income (%): 1.5027937619881577
Buffett classification: The Great
Stock price: 132.33
P/E ratio: 32.10213223331267
Shares outstanding: 35217007
Book value: 529403000
P/B ratio: 8.802871416123446
Market cap (USD): 4660266536.31
Debt to equity: 0.10315204107267999
Current ratio: 1.3819815646857196
Quick ratio: 1.3819815646857196
Effective tax rate (%): 22.879201004871174
COGS to revenue (%): 16.36312263806642
R&D to revenue (%): 17.027701581097467
SG&A to revenue (%): 31.31703182208827
Free cash flow (dilution-adjusted): 70034000
Buyback yield (%): 1.0559267290098753
Retained earnings: -176873000
Receivables turnover: 1.3228830849257893
Capitalized R&D asset: 58814650
ROCI (R&D-adjusted, %): 9.019200853666886
Rosenberg metric: 0.22807365532744883
FCF margin (%): 41.225085647684864
Revenue growth (%): 3.547439382672404
Rule of 40 score: 44.772525030357265
Financial ratios for QLYS — quarterly report dated 2025-12-31
Total revenue: 175282000
Gross profit: 146115000
Operating income: 58835000
Net income: 53150000
Capital expenditures: 724000
Operating cash flow: 75659000
Depreciation & amortization: 3138000
Net tangible assets: 549451000
Owner earnings: 55564000
Return on net tangible assets (%): 10.11263970763544
Capex to operating income (%): 1.2305600407920456
Buffett classification: The Great
Stock price: 132.9
P/E ratio: 23.599940652985076
Shares outstanding: 35217007
Book value: 561153000
P/B ratio: 8.34057775740306
Market cap (USD): 4680340230.3
Debt to equity: 0.09315462984248503
Current ratio: 1.4071528529672315
Quick ratio: 1.4071528529672315
Effective tax rate (%): 17.50225064414988
COGS to revenue (%): 16.64004290229459
R&D to revenue (%): 16.5185244349106
SG&A to revenue (%): 33.27552173069682
Free cash flow (dilution-adjusted): 54282000
Buyback yield (%): 0.9544391604440406
Retained earnings: -166659000
Receivables turnover: 1.0250948880350428
Capitalized R&D asset: 58317260
ROCI (R&D-adjusted, %): 8.514169489037789
Rosenberg metric: 0.13935077954851868
FCF margin (%): 30.968382378110704
Revenue growth (%): 3.1786769640103127
Rule of 40 score: 34.14705934212102
Financial ratios for QLYS — annual report dated 2025-12-31
Total revenue: 669125000
Gross profit: 554357000
Operating income: 221952000
Net income: 198320000
Capital expenditures: 4990000
Operating cash flow: 309400000
Depreciation & amortization: 14491000
Net tangible assets: 549451000
Owner earnings: 207821000
Return on net tangible assets (%): 37.8233909848194
Capex to operating income (%): 2.2482338523644754
Buffett classification: The Great
Stock price: 132.9
P/E ratio: 23.599940652985076
Shares outstanding: 35217007
Book value: 561153000
P/B ratio: 8.34057775740306
Market cap (USD): 4680340230.3
Debt to equity: 0.09315462984248503
Current ratio: 1.4071528529672315
Quick ratio: 1.4071528529672315
Effective tax rate (%): 19.65255157437568
COGS to revenue (%): 17.15195217634971
R&D to revenue (%): 17.527965626751353
SG&A to revenue (%): 32.14959835606202
Free cash flow (dilution-adjusted): 227444000
Buyback yield (%): 3.919052696479778
Retained earnings: -166659000
Receivables turnover: 3.913217654730366
Capitalized R&D asset: 228680600
ROCI (R&D-adjusted, %): 26.392702552023707
Rosenberg metric: 0.520938382863069
FCF margin (%): 33.99125723893144
Revenue growth (%): 10.131161625554872
Rule of 40 score: 44.12241886448631
Financial ratios for QTI — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 148.35
Shares outstanding: 13768903
Market cap (USD): 2042616760.05
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTI — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -4279100
Net income: -2774307
Capital expenditures: 22600
Operating cash flow: -1261550
Depreciation & amortization: 651750
Net tangible assets: 28527372
Owner earnings: -2145157
Return on net tangible assets (%): -7.519644641644523
Buffett classification: The Gruesome
Stock price: 153
Shares outstanding: 13768903
Book value: 28527372
P/B ratio: 73.84634515229794
Market cap (USD): 2106642159
Debt to equity: 0.2601106754593448
Current ratio: 0.05988535732021721
Quick ratio: -1.0816460638367247
Interest coverage ratio: -185.25846393627154
Free cash flow (dilution-adjusted): -2052305
Buyback yield (%): 9.12059559708071
Retained earnings: -13080129
Inventory turnover: 0.11653817840317428
Capitalized R&D asset: 2386086
ROCI (R&D-adjusted, %): -6.696621553658966
Rule of 40 score: 0
Financial ratios for QTI — annual report dated 2023-12-31
Total revenue: 40355
Gross profit: -94633
Operating income: -5007959
Net income: -6098951
Capital expenditures: 13040
Operating cash flow: -2651143
Depreciation & amortization: 480694
Net tangible assets: -5402218
Owner earnings: -5631297
Buffett classification: The Gruesome
Stock price: 164.85
Shares outstanding: 13768903
Book value: -5312079
Market cap (USD): 2269803659.5499997
Debt to equity: -1.8011793499306015
Current ratio: 0.6566989836680748
Quick ratio: 0.0546375671480445
Interest coverage ratio: -9.191850242095642
COGS to revenue (%): 334.50130095403296
R&D to revenue (%): 3681.4174203940033
SG&A to revenue (%): 12210.628174947342
Free cash flow (dilution-adjusted): -3373577
Buyback yield (%): 0.8933647152555981
Retained earnings: -17770145
Inventory turnover: 0.030552734520438992
Receivables turnover: 31.282945736434108
Capitalized R&D asset: 3084313.62
ROCI (R&D-adjusted, %): -196.25679994616746
Rosenberg metric: -0.03966034753148043
FCF margin (%): -8359.749721224136
Rule of 40 score: -8359.749721224136
Financial ratios for QTI — quarterly report dated 2024-09-30
Capital expenditures: 7613
Depreciation & amortization: 19508
Buffett classification: The Gruesome
Stock price: 3.55
Shares outstanding: 13768903
Market cap (USD): 48879605.65
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTI — quarterly report dated 2024-12-31
Capital expenditures: 53200
Depreciation & amortization: 26521
Buffett classification: The Gruesome
Stock price: 2.44
Shares outstanding: 13768903
Market cap (USD): 33596123.32
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for QTI — annual report dated 2024-12-31
Total revenue: 4879000
Gross profit: 2640000
Operating income: -12177000
Net income: -8985000
Capital expenditures: 88000
Operating cash flow: -10033000
Depreciation & amortization: 231000
Net tangible assets: -9538000
Owner earnings: -8842000
Buffett classification: The Gruesome
Stock price: 2.44
Shares outstanding: 13768903
Book value: -9538000
Market cap (USD): 33596123.32
Debt to equity: -1.0386873558397987
Current ratio: 0.5020420665713702
Quick ratio: 0.18133551153767613
Interest coverage ratio: -2.7072032014228546
COGS to revenue (%): 45.890551342488216
R&D to revenue (%): 66.96044271367083
SG&A to revenue (%): 236.72883787661405
Free cash flow (dilution-adjusted): -10411000
Buyback yield (%): 0
Retained earnings: -31941000
Inventory turnover: 0.7128303088188475
Receivables turnover: 72.82089552238806
Capitalized R&D asset: 5049784.5
ROCI (R&D-adjusted, %): -840.7584389006577
Rosenberg metric: 1.8407153569245764
FCF margin (%): -213.3838901414224
Revenue growth (%): 11990.199479618386
Rule of 40 score: 11776.815589476964
Financial ratios for QTI — quarterly report dated 2025-03-31
Total revenue: 2798000
Gross profit: 1812000
Operating income: -1042000
Net income: -11136000
Capital expenditures: 0
Operating cash flow: -3536000
Depreciation & amortization: 38000
Net tangible assets: -20207358
Owner earnings: -11098000
Buffett classification: The Gruesome
Stock price: 3
Shares outstanding: 13768903
Book value: -20207358
Market cap (USD): 41306709
Debt to equity: -0.24143952910618002
Current ratio: 1.8577856289803265
Quick ratio: 1.3140484384787252
Interest coverage ratio: -1.507959479015919
COGS to revenue (%): 35.23945675482488
R&D to revenue (%): 30.45032165832738
SG&A to revenue (%): 71.55110793423874
Free cash flow (dilution-adjusted): -3637000
Buyback yield (%): 0
Retained earnings: -43076527
Inventory turnover: 0.3432668349579324
Receivables turnover: 1.0056052248343519
Capitalized R&D asset: 852000
ROCI (R&D-adjusted, %): -7.367138552096161
FCF margin (%): -129.9857040743388
Rule of 40 score: -129.9857040743388
Financial ratios for QTI — quarterly report dated 2025-06-30
Total revenue: 3659414
Gross profit: 1827077
Operating income: -1042979
Net income: -4001515
Capital expenditures: 46818
Operating cash flow: -1442822
Depreciation & amortization: 37924
Net tangible assets: -324294
Owner earnings: -4010409
Buffett classification: The Gruesome
Stock price: 6.67
Shares outstanding: 13768903
Book value: -324294
Market cap (USD): 91838583.01
Debt to equity: -14.874727870389215
Current ratio: 1.6915604581213246
Quick ratio: 1.1792195370551106
Interest coverage ratio: -2.752635246053069
COGS to revenue (%): 50.07186943046072
R&D to revenue (%): 24.613066463646913
SG&A to revenue (%): 53.816321411023736
Free cash flow (dilution-adjusted): -1708566
Buyback yield (%): 0
Retained earnings: -47078042
Inventory turnover: 0.5670942199834236
Receivables turnover: 0.8477783376481968
Capitalized R&D asset: 1471534
ROCI (R&D-adjusted, %): -10.689075015365047
Rosenberg metric: 0.01769600938967136
FCF margin (%): -46.689606587284196
Revenue growth (%): 30.786776268763404
Rule of 40 score: -15.902830318520792
Financial ratios for QTI — quarterly report dated 2025-09-30
Total revenue: 4192101
Gross profit: 1802673
Operating income: -1652079
Net income: -4557406
Capital expenditures: 0
Operating cash flow: -878750
Depreciation & amortization: 39550
Net tangible assets: -9076444
Owner earnings: -4517856
Buffett classification: The Gruesome
Stock price: 11.82
Shares outstanding: 13768903
Book value: -9076444
Market cap (USD): 162748433.46
Debt to equity: -1.09666968693907
Current ratio: 0.8858385321184432
Quick ratio: 0.47445369693085887
Interest coverage ratio: -2.925457523573421
COGS to revenue (%): 56.99834045028972
R&D to revenue (%): 22.39349672157231
SG&A to revenue (%): 60.017494807496284
Free cash flow (dilution-adjusted): -1077545
Buyback yield (%): 0
Retained earnings: -51635448
Inventory turnover: 0.45580390627801765
Receivables turnover: 1.283145258522135
Capitalized R&D asset: 1823382.98
ROCI (R&D-adjusted, %): -134.04478560161604
Rosenberg metric: -0.027094662560203576
FCF margin (%): -25.704175543480467
Revenue growth (%): 14.55662026761662
Rule of 40 score: -11.147555275863848
Financial ratios for QTI — quarterly report dated 2025-12-31
Total revenue: 8275070
Gross profit: 3142388
Operating income: -700211
Net income: -1388079
Capital expenditures: 77182
Operating cash flow: -3101428
Depreciation & amortization: 15526
Net tangible assets: 6445000
Owner earnings: -1449735
Return on net tangible assets (%): -22.493948797517454
Buffett classification: The Gruesome
Stock price: 6.1
Shares outstanding: 13768903
Book value: 6445000
P/B ratio: 13.031855438324282
Market cap (USD): 83990308.3
Debt to equity: 0.8136539953452289
Current ratio: 2.807702084392476
Quick ratio: 2.1687849517031013
Interest coverage ratio: -0.6974310398750581
COGS to revenue (%): 62.02584389014232
R&D to revenue (%): 15.03668246915132
SG&A to revenue (%): 31.39916641188534
Free cash flow (dilution-adjusted): -3460889
Buyback yield (%): 0
Retained earnings: -53024000
Inventory turnover: 1.0210228764670777
Receivables turnover: 1.4314253589344403
Capitalized R&D asset: 2170492.88
ROCI (R&D-adjusted, %): -2.792918283578848
Rosenberg metric: 1.4271143361760965
FCF margin (%): -41.82307823377929
Revenue growth (%): 97.39672302742706
Rule of 40 score: 55.573644793647766
Financial ratios for QTI — annual report dated 2025-12-31
Total revenue: 18925000
Gross profit: 8584000
Operating income: -4437000
Net income: -21083000
Capital expenditures: 124000
Operating cash flow: -8959000
Depreciation & amortization: 131000
Net tangible assets: 6445000
Owner earnings: -21076000
Return on net tangible assets (%): -327.0131885182312
Buffett classification: The Gruesome
Stock price: 6.1
Shares outstanding: 13768903
Book value: 6445000
P/B ratio: 13.031855438324282
Market cap (USD): 83990308.3
Debt to equity: 0.8136539953452289
Current ratio: 2.807702084392476
Quick ratio: 2.1687849517031013
Interest coverage ratio: -1.6813186813186813
COGS to revenue (%): 54.64200792602378
R&D to revenue (%): 20.797886393659184
SG&A to revenue (%): 48.00528401585205
Free cash flow (dilution-adjusted): -9884000
Buyback yield (%): 0
Retained earnings: -53024000
Inventory turnover: 2.0570917047941117
Receivables turnover: 3.2736550769763015
Capitalized R&D asset: 6615149.88
ROCI (R&D-adjusted, %): -15.606342379704344
Rosenberg metric: 1.8194061830425468
FCF margin (%): -52.22721268163804
Revenue growth (%): 287.8868620618979
Rule of 40 score: 235.65964938025985
Financial ratios for QUMS — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -596977
Net income: -90319
Capital expenditures: 0
Operating cash flow: -563135
Net tangible assets: 80530634
Owner earnings: -90319
Return on net tangible assets (%): -0.11215483538848087
Buffett classification: The Gruesome
Stock price: 9.96
Shares outstanding: 10936105
Book value: 80530634
P/B ratio: 1.3525735535622383
Market cap (USD): 108923605.80000001
Debt to equity: 0
Current ratio: 11.758732057416267
Quick ratio: 11.758732057416267
Free cash flow (dilution-adjusted): -563135
Buyback yield (%): 0
Retained earnings: -2772655
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.7120208079340636
Rule of 40 score: 0
Financial ratios for QUMS — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -284738
Net income: 521600
Capital expenditures: 0
Operating cash flow: -308645
Net tangible assets: 81052234
Owner earnings: 521600
Return on net tangible assets (%): 0.6435356242000683
Buffett classification: The Gruesome
Stock price: 10.01
P/E ratio: 263.26267260991483
Shares outstanding: 10936105
Book value: 81052234
P/B ratio: 1.3506155925325884
Market cap (USD): 109470411.05
Debt to equity: 0
Current ratio: 2.54578191149094
Quick ratio: 2.54578191149094
Free cash flow (dilution-adjusted): -308645
Buyback yield (%): 0
Retained earnings: -3054661
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.33751032457664465
Rule of 40 score: 0
Financial ratios for SBUX.TO — quarterly report dated 2025-12-31
Total revenue: 7237299270.072992
Gross profit: 1524963503.6496348
Operating income: 670291970.8029196
Net income: 214087591.2408759
Capital expenditures: 236277372.2627737
Operating cash flow: 1166204379.5620437
Depreciation & amortization: 315255474.4525547
Net tangible assets: -7202189781.021897
Owner earnings: 293065693.4306569
Return on net tangible assets (%): -4.06911928651059
Capex to operating income (%): 35.249918327344005
Buffett classification: The Good
Stock price: 16.956204379562042
P/E ratio: 93.69977943963322
Shares outstanding: 5450008237
Book value: -6117737226.27737
Market cap (USD): 92411453536.8686
Debt to equity: -3.0390154272010315
Current ratio: 1.0466630682708546
Quick ratio: 0.8625877108979159
Effective tax rate (%): 61.66317991631798
Interest coverage ratio: 6.606474820143885
COGS to revenue (%): 78.92910812800677
SG&A to revenue (%): 6.442698510352896
Free cash flow (dilution-adjusted): 837883211.678832
Buyback yield (%): 0
Retained earnings: -6339708029.19708
Inventory turnover: 3.70123912220961
Receivables turnover: 8.132463910761155
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.427313093912264
FCF margin (%): 11.57729120230759
Revenue growth (%): 5.129543164400232
Rule of 40 score: 16.706834366707824
Financial ratios for SGA.AX — annual report dated 2023-06-30
Operating income: -1501679.4701986755
Net income: -1349680.132450331
Capital expenditures: 47166.225165562915
Depreciation & amortization: 1715.23178807947
Net tangible assets: 16157516.55629139
Owner earnings: -1395131.1258278145
Return on net tangible assets (%): -8.634564111181927
Buffett classification: The Gruesome
Stock price: 0.152317880794702
Shares outstanding: 264800892
Book value: 16157516.55629139
P/B ratio: 2.4962939422940957
Market cap (USD): 40333910.70198675
Debt to equity: 0
Current ratio: 56.18502141771452
Quick ratio: 56.18502141771452
Interest coverage ratio: -718.4841571609632
Free cash flow (dilution-adjusted): -3244423.178807947
Buyback yield (%): 1.494842593558609
Retained earnings: -6663847.682119206
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -9.293999266328797
Rule of 40 score: 0
Financial ratios for SHOE.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007432432432432433
Shares outstanding: 46226830
Market cap (USD): 343577.79054054053
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOE.L — annual report dated 2022-09-30
Total revenue: 173515555.55555555
Gross profit: 40444444.44444444
Operating income: 16306666.666666666
Net income: 12050000
Capital expenditures: 1816666.6666666665
Operating cash flow: 32522222.22222222
Depreciation & amortization: 19037777.777777776
Net tangible assets: 41381111.11111111
Owner earnings: 29271111.11111111
Return on net tangible assets (%): 70.73544021695352
Capex to operating income (%): 11.140637775960752
Buffett classification: The Great
Stock price: 0.015666666666666666
P/E ratio: 0.06010127275242046
Shares outstanding: 46226830
Book value: 41381111.11111112
P/B ratio: 0.017501229841849472
Market cap (USD): 724220.3366666667
Debt to equity: 0.9624627446768518
Current ratio: 1.5406129420727959
Quick ratio: 0.7495391874953918
Effective tax rate (%): 20.039814200398144
Interest coverage ratio: 13.221621621621622
COGS to revenue (%): 76.69117082041956
SG&A to revenue (%): 13.911016623549601
Free cash flow (dilution-adjusted): 26716666.666666664
Buyback yield (%): 148.2053567113997
Retained earnings: 37142222.222222224
Inventory turnover: 3.7207655026718034
Receivables turnover: 124.9312
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.10643889618922
FCF margin (%): 15.397274659972847
Rule of 40 score: 15.397274659972847
Financial ratios for SHOE.L — annual report dated 2023-09-30
Total revenue: 202020731.70731708
Gross profit: 49819512.19512195
Operating income: 20426829.268292684
Net income: 16121951.219512196
Capital expenditures: 13285365.853658536
Operating cash flow: 39552439.02439024
Depreciation & amortization: 20457317.073170733
Net tangible assets: 40673170.73170732
Owner earnings: 23293902.439024396
Return on net tangible assets (%): 57.270928280163126
Capex to operating income (%): 65.03880597014926
Buffett classification: The Good
Stock price: 0.02475609756097561
P/E ratio: 0.0709837102118003
Shares outstanding: 46226830
Book value: 40673170.73170732
P/B ratio: 0.028136383095466535
Market cap (USD): 1144395.9134146343
Debt to equity: 1.0581074598224993
Current ratio: 1.3883745123537061
Quick ratio: 0.5105591677503252
Effective tax rate (%): 18.304288715857123
Interest coverage ratio: 22.513440860215052
COGS to revenue (%): 75.33940612228884
SG&A to revenue (%): 14.549339901120991
Free cash flow (dilution-adjusted): 25684146.341463417
Buyback yield (%): 759.2673381992164
Retained earnings: 36314634.146341465
Inventory turnover: 3.697706802559849
Receivables turnover: 403.05839416058393
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 27.735920915368183
FCF margin (%): 12.713619104535276
Revenue growth (%): 16.428023447520157
Rule of 40 score: 29.141642552055433
Financial ratios for SHOE.L — annual report dated 2024-09-30
Total revenue: 215096000
Gross profit: 47360000
Operating income: 15093333.333333334
Net income: 9889333.333333334
Capital expenditures: 15340000
Operating cash flow: 27968000
Depreciation & amortization: 23600000
Net tangible assets: 43525333.333333336
Owner earnings: 18149333.333333336
Return on net tangible assets (%): 41.69832128415636
Capex to operating income (%): 101.63427561837455
Buffett classification: The Gruesome
Stock price: 0.02266666666666667
P/E ratio: 0.1059533652420116
Shares outstanding: 46226830
Book value: 43525333.33333333
P/B ratio: 0.024073523771596623
Market cap (USD): 1047808.1466666667
Debt to equity: 1.1679941183678473
Current ratio: 1.1619539830045222
Quick ratio: 0.21897828355612975
Effective tax rate (%): 26.680506128904703
Interest coverage ratio: 8.091493924231594
COGS to revenue (%): 77.98192435005765
SG&A to revenue (%): 15.00105379303505
Free cash flow (dilution-adjusted): 12628000
Buyback yield (%): 0
Retained earnings: 39409333.333333336
Inventory turnover: 3.3148533635477326
Receivables turnover: 370.8551724137931
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.770934898683382
FCF margin (%): 5.870866961728717
Revenue growth (%): 6.472240834978294
Rule of 40 score: 12.34310779670701
Financial ratios for SHOE.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 43525333.333333336
Buffett classification: The Gruesome
Stock price: 0.02266666666666667
Shares outstanding: 46226830
Book value: 43525333.33333333
P/B ratio: 0.024073523771596623
Market cap (USD): 1047808.1466666667
Debt to equity: 1.1679941183678473
Current ratio: 1.1619539830045222
Quick ratio: 0.21897828355612975
Buyback yield (%): 0
Retained earnings: 39409333.333333336
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOE.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 40258441.55844156
Buffett classification: The Gruesome
Stock price: 0.012467532467532466
Shares outstanding: 46226830
Book value: 40258441.558441564
P/B ratio: 0.014315867221523271
Market cap (USD): 576334.5038961038
Debt to equity: 0
Buyback yield (%): 0
Retained earnings: 35712987.01298701
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOE.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 48736486.48648649
Buffett classification: The Gruesome
Stock price: 0.009864864864864865
Shares outstanding: 46226830
Book value: 48736486.486486495
P/B ratio: 0.009356879495355606
Market cap (USD): 456021.4310810811
Debt to equity: 0.9595175377790099
Current ratio: 1.36162139943719
Quick ratio: 0.33152053625067196
Buyback yield (%): 0
Retained earnings: 44227027.027027026
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SHOE.L — annual report dated 2025-09-30
Total revenue: 201479729.72972974
Gross profit: 37347297.2972973
Operating income: 6444594.594594595
Net income: 2552702.702702703
Capital expenditures: 4467567.567567567
Operating cash flow: 27674324.324324325
Depreciation & amortization: 25106756.756756756
Net tangible assets: 48736486.48648649
Owner earnings: 23191891.891891893
Return on net tangible assets (%): 47.586302509358106
Capex to operating income (%): 69.3227091633466
Buffett classification: The Good
Stock price: 0.009864864864864865
P/E ratio: 0.17864259343568023
Shares outstanding: 46226830
Book value: 48736486.486486495
P/B ratio: 0.009356879495355606
Market cap (USD): 456021.4310810811
Debt to equity: 0.9595175377790099
Current ratio: 1.36162139943719
Quick ratio: 0.33152053625067196
Effective tax rate (%): 41.984029484029485
Interest coverage ratio: 3.0414540816326534
COGS to revenue (%): 81.46349642845165
SG&A to revenue (%): 15.337871826687682
Free cash flow (dilution-adjusted): 23206756.756756756
Buyback yield (%): 0
Retained earnings: 44227027.027027026
Inventory turnover: 3.728107062831886
Receivables turnover: 434.67930029154525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.053566603620641
FCF margin (%): 11.518159562694926
Revenue growth (%): -6.33032240035624
Rule of 40 score: 5.187837162338686
Financial ratios for SURAJEST.NS — annual report dated 2024-03-31
Total revenue: 49432066.19498741
Gross profit: 33234800.335771676
Operating income: 27660390.934164766
Net income: 8094615.661350282
Capital expenditures: 3039453.1718431464
Operating cash flow: 1080944.9574289483
Depreciation & amortization: 274613.2629811728
Net tangible assets: 60601990.64636047
Owner earnings: 5329775.752488308
Return on net tangible assets (%): 8.79472059521925
Capex to operating income (%): 10.98846787479407
Buffett classification: The Great
Stock price: 3.124640115163148
P/E ratio: 18.441226962115323
Shares outstanding: 47773388
Book value: 61903945.317184314
P/B ratio: 2.4113914519857857
Market cap (USD): 149274644.58205375
Debt to equity: 0.8325878458090299
Current ratio: 2.364672010168862
Quick ratio: 0.9496936132578071
Effective tax rate (%): 28.10116333574807
Interest coverage ratio: 1.6932156856987652
COGS to revenue (%): 32.7667182579922
SG&A to revenue (%): 2.698355708442702
Free cash flow (dilution-adjusted): -1958508.2144141984
Buyback yield (%): 0
Retained earnings: 16131310.70871807
Inventory turnover: 0.18273433853521925
Receivables turnover: 3.864530403315021
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 30.0337368473821
FCF margin (%): -3.962019727617209
Revenue growth (%): 32.73760514052494
Rule of 40 score: 28.77558541290773
Financial ratios for SURAJEST.NS — quarterly report dated 2024-09-30
Total revenue: 13030458.67176302
Gross profit: 9165671.285236502
Operating income: 7435499.28332537
Net income: 3802197.8021978023
Capital expenditures: 0
Depreciation & amortization: 142857.14285714287
Net tangible assets: 67094362.15957955
Owner earnings: 3945054.945054945
Return on net tangible assets (%): 5.879860569613718
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.31438127090301
P/E ratio: 29.258048475119374
Shares outstanding: 47773388
Book value: 68142618.25131391
P/B ratio: 6.530121117355255
Market cap (USD): 444979550.43478256
Debt to equity: 0.7869024873354484
Current ratio: 2.367719640277516
Quick ratio: 0.9845458688395939
Effective tax rate (%): 27.18622046343528
Interest coverage ratio: 3.2624076306273255
COGS to revenue (%): 29.659641950298376
Buyback yield (%): 0
Inventory turnover: 0.041160419542167294
Receivables turnover: 1.1561148791860958
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.49512365448985
Rule of 40 score: 0
Financial ratios for SURAJEST.NS — quarterly report dated 2024-12-31
Total revenue: 19797995.104324512
Gross profit: 6903601.818393752
Operating income: 5189882.270660915
Net income: 2329409.0220305393
Capital expenditures: 0
Depreciation & amortization: 150134.04825737263
Owner earnings: 2479543.070287912
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 7.066674437580137
P/E ratio: 36.2322563988691
Shares outstanding: 47773388
Market cap (USD): 337598979.7761977
Effective tax rate (%): 23.182779165865846
Interest coverage ratio: 2.17349279960947
COGS to revenue (%): 65.12979328454432
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 51.936287148715124
Rule of 40 score: 51.936287148715124
Financial ratios for SURAJEST.NS — annual report dated 2025-03-31
Total revenue: 64191255.55295768
Gross profit: 29523497.778816927
Operating income: 23109878.419452887
Net income: 11709609.539396772
Capital expenditures: 330839.3733925649
Operating cash flow: -32135714.285714284
Depreciation & amortization: 580453.5889642272
Net tangible assets: 104315057.28314239
Owner earnings: 11959223.754968435
Return on net tangible assets (%): 11.464523019440529
Capex to operating income (%): 1.431592877243693
Buffett classification: The Great
Stock price: 3.5342513712218464
P/E ratio: 14.419196599070489
Shares outstanding: 47773388
Book value: 105532850.1285948
P/B ratio: 1.599910945655055
Market cap (USD): 168843162.0469133
Debt to equity: 0.5105690750702315
Current ratio: 3.4792351194075435
Quick ratio: 1.6261440105602551
Effective tax rate (%): 26.391743030260272
Interest coverage ratio: 3.008751596215049
COGS to revenue (%): 54.006978794081874
SG&A to revenue (%): 2.5831736758138892
Free cash flow (dilution-adjusted): -32466553.659106847
Buyback yield (%): 0
Retained earnings: 26903320.084171146
Inventory turnover: 0.32801732624532387
Receivables turnover: 9.711738799766533
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.705405712460685
FCF margin (%): -50.57784487845388
Revenue growth (%): 29.85752062184061
Rule of 40 score: -20.72032425661327
Financial ratios for SURAJEST.NS — quarterly report dated 2025-03-31
Total revenue: 15955237.315875612
Gross profit: 5035784.42833762
Operating income: 3427577.7414075285
Net income: 2138484.919335983
Capital expenditures: 0
Depreciation & amortization: 91162.0294599018
Net tangible assets: 104315057.28314239
Owner earnings: 2229646.948795885
Return on net tangible assets (%): 2.1374162147502385
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.5342513712218464
P/E ratio: 19.738643059888922
Shares outstanding: 47773388
Book value: 105532850.1285948
P/B ratio: 1.599910945655055
Market cap (USD): 168843162.0469133
Debt to equity: 0.5105690750702315
Current ratio: 3.4792351194075435
Quick ratio: 1.6261440105602551
Effective tax rate (%): 29.699673139780813
Interest coverage ratio: 7.336294257475291
COGS to revenue (%): 68.43804746591286
Buyback yield (%): 0
Retained earnings: 26903320.084171146
Inventory turnover: 0.10331702914180664
Receivables turnover: 2.4139284387767734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.3293717977543267
Revenue growth (%): -19.40983300682562
Rule of 40 score: -19.40983300682562
Financial ratios for SURAJEST.NS — quarterly report dated 2025-06-30
Total revenue: 15500702.082845777
Gross profit: 7064825.649426633
Operating income: 5671191.200561667
Net income: 2490287.8539667684
Capital expenditures: 0
Depreciation & amortization: 131523.5197753335
Owner earnings: 2621811.3737421017
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 4.323075122864498
P/E ratio: 19.193369836612455
Shares outstanding: 47773388
Market cap (USD): 206527945.19775334
Effective tax rate (%): 25.27125250184346
Interest coverage ratio: 2.3465672508957103
COGS to revenue (%): 54.422544142403126
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.848815244995247
Rule of 40 score: -2.848815244995247
Financial ratios for SURAJEST.NS — quarterly report dated 2025-12-31
Total revenue: 20057034.644090455
Gross profit: 7591734.432438455
Operating income: 5824997.215105269
Net income: 2803386.4319928708
Capital expenditures: 0
Depreciation & amortization: 144146.1512754818
Owner earnings: 2947532.583268353
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.9302662359362817
P/E ratio: 14.340804937551363
Shares outstanding: 47773388
Market cap (USD): 139988745.83268353
Effective tax rate (%): 26.3096249011742
Interest coverage ratio: 2.671724913141222
COGS to revenue (%): 62.14926798924755
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 29.394362506244487
Rule of 40 score: 29.394362506244487
Financial ratios for SYRE — annual report dated 2021-12-31
Net income: -65801000
Capital expenditures: 573000
Owner earnings: -66374000
Buffett classification: The Gruesome
Stock price: 118.75
Shares outstanding: 86841253
Market cap (USD): 10312398793.75
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYRE — annual report dated 2022-12-31
Total revenue: 503132.43
Operating income: -84781000
Net income: -83815000
Capital expenditures: 38000
Operating cash flow: -80144000
Depreciation & amortization: 1964000
Net tangible assets: 50305000
Owner earnings: -81889000
Return on net tangible assets (%): -162.78501143027532
Buffett classification: The Gruesome
Stock price: 11.25
Shares outstanding: 86841253
Book value: 50305000
P/B ratio: 19.42081495378193
Market cap (USD): 976964096.25
Debt to equity: 0.09201868601530663
Current ratio: 4.247953056768559
Quick ratio: 4.247953056768559
COGS to revenue (%): 0
R&D to revenue (%): 11642.859117628335
SG&A to revenue (%): 5670.674021151846
Free cash flow (dilution-adjusted): -87293000
Buyback yield (%): 0
Retained earnings: -425624000
Receivables turnover: 1.34168648
Capitalized R&D asset: 58579000
ROCI (R&D-adjusted, %): -39.740614888137635
FCF margin (%): -17349.90527245481
Rule of 40 score: -17349.90527245481
Financial ratios for SYRE — annual report dated 2023-12-31
Total revenue: 886000
Operating income: -128564000
Net income: -338790000
Capital expenditures: 475000
Operating cash flow: -99910000
Depreciation & amortization: 744000
Net tangible assets: 184016000
Owner earnings: -338521000
Return on net tangible assets (%): -183.9628075819494
Buffett classification: The Gruesome
Stock price: 21.52
Shares outstanding: 86841253
Book value: 184016000
P/B ratio: 10.155767784105729
Market cap (USD): 1868823764.56
Debt to equity: 0
Current ratio: 10.680092563637501
Quick ratio: 10.680092563637501
COGS to revenue (%): 0
R&D to revenue (%): 10102.031602708805
SG&A to revenue (%): 4508.577878103837
Free cash flow (dilution-adjusted): -125585000
Buyback yield (%): 0
Retained earnings: -764414000
Capitalized R&D asset: 128751930
ROCI (R&D-adjusted, %): -20.158313239272758
FCF margin (%): -14174.379232505644
Revenue growth (%): 76.096778337266
Rule of 40 score: -14098.282454168379
Financial ratios for SYRE — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 29.41
Shares outstanding: 86841253
Market cap (USD): 2554001250.73
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYRE — annual report dated 2024-12-31
Total revenue: 0
Operating income: -208566000
Net income: -208018000
Capital expenditures: 0
Operating cash flow: -157410000
Depreciation & amortization: 0
Net tangible assets: 517804000
Owner earnings: -208018000
Return on net tangible assets (%): -40.17311569628663
Buffett classification: The Gruesome
Stock price: 23.28
Shares outstanding: 86841253
Book value: 517804000
P/B ratio: 3.904304273122649
Market cap (USD): 2021664369.8400002
Debt to equity: 0
Current ratio: 11.255530891601923
Quick ratio: 11.255530891601923
Free cash flow (dilution-adjusted): -202243000
Buyback yield (%): 0
Retained earnings: -972432000
Capitalized R&D asset: 242088750
ROCI (R&D-adjusted, %): -18.756803746497884
Revenue growth (%): -100
Rule of 40 score: -100
Financial ratios for SYRE — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 23.28
Shares outstanding: 86841253
Market cap (USD): 2021664369.8400002
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SYRE — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -53567000
Net income: -44773000
Capital expenditures: 0
Operating cash flow: -40994000
Net tangible assets: 482610000
Owner earnings: -44773000
Return on net tangible assets (%): -9.277263214603924
Buffett classification: The Gruesome
Stock price: 16.14
Shares outstanding: 86841253
Book value: 482610000
P/B ratio: 2.90424529831541
Market cap (USD): 1401617823.42
Debt to equity: 0
Current ratio: 8.061461841025496
Quick ratio: 8.061461841025496
Free cash flow (dilution-adjusted): -49853000
Buyback yield (%): 0.008347496588942885
Retained earnings: -1017205000
Capitalized R&D asset: 41623000
ROCI (R&D-adjusted, %): -4.774779939698022
Rule of 40 score: 0
Financial ratios for SYRE — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -51935000
Net income: -36717000
Capital expenditures: 0
Operating cash flow: -46563000
Net tangible assets: 455773000
Owner earnings: -36717000
Return on net tangible assets (%): -8.055984009583717
Buffett classification: The Gruesome
Stock price: 14.97
Shares outstanding: 86841253
Book value: 455773000
P/B ratio: 2.8523268324582634
Market cap (USD): 1300013557.41
Debt to equity: 0
Current ratio: 6.487340324347753
Quick ratio: 6.487340324347753
Free cash flow (dilution-adjusted): -55941000
Buyback yield (%): 0
Retained earnings: -1053922000
Capitalized R&D asset: 68032410
ROCI (R&D-adjusted, %): -7.4542949069579105
Rule of 40 score: 0
Financial ratios for SYRE — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -56888000
Net income: -11183000
Capital expenditures: 0
Operating cash flow: -37117000
Net tangible assets: 455100000
Owner earnings: -11183000
Return on net tangible assets (%): -2.4572621401889694
Buffett classification: The Gruesome
Stock price: 16.76
Shares outstanding: 86841253
Book value: 455100000
P/B ratio: 3.1981089876510658
Market cap (USD): 1455459400.2800002
Debt to equity: 0
Current ratio: 10.904698102606215
Quick ratio: 10.904698102606215
Free cash flow (dilution-adjusted): -46683000
Buyback yield (%): 0
Retained earnings: -1065105000
Capitalized R&D asset: 85879740
ROCI (R&D-adjusted, %): -9.91884734244803
Rule of 40 score: 0
Financial ratios for SYRE — annual report dated 2025-12-31
Total revenue: 0
Operating income: -219562000
Net income: -155203000
Capital expenditures: 0
Operating cash flow: -169252000
Depreciation & amortization: 0
Net tangible assets: 715236000
Owner earnings: -155203000
Return on net tangible assets (%): -21.699550917459412
Buffett classification: The Gruesome
Stock price: 32.76
Shares outstanding: 86841253
Book value: 715236000
P/B ratio: 3.977595434625773
Market cap (USD): 2844919448.2799997
Debt to equity: 0
Current ratio: 13.253488966516146
Quick ratio: 13.253488966516146
Free cash flow (dilution-adjusted): -206866000
Buyback yield (%): 0
Retained earnings: -1127635000
Capitalized R&D asset: 310258620
ROCI (R&D-adjusted, %): -18.382845230409192
Rule of 40 score: 0
Financial ratios for SYRE — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -57172000
Net income: -62530000
Capital expenditures: 0
Operating cash flow: -44578000
Net tangible assets: 715236000
Owner earnings: -62530000
Return on net tangible assets (%): -8.742568886353595
Buffett classification: The Gruesome
Stock price: 32.76
Shares outstanding: 86841253
Book value: 715236000
P/B ratio: 3.977595434625773
Market cap (USD): 2844919448.2799997
Debt to equity: 0
Current ratio: 13.253488966516146
Quick ratio: 13.253488966516146
Free cash flow (dilution-adjusted): -54389000
Buyback yield (%): 0
Retained earnings: -1127635000
Capitalized R&D asset: 88201340
ROCI (R&D-adjusted, %): -6.921530713000161
Rule of 40 score: 0
Financial ratios for TBLD.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.025405405405405403
Shares outstanding: 393281732
Market cap (USD): 9991481.839999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TBLD.L — annual report dated 2022-12-31
Total revenue: 63295000
Gross profit: 42608000
Operating income: 17554000
Net income: 11545000
Capital expenditures: 1180000
Operating cash flow: 19268000
Depreciation & amortization: 10524000
Net tangible assets: 31250000
Owner earnings: 20889000
Return on net tangible assets (%): 66.8448
Capex to operating income (%): 6.7221146177509405
Buffett classification: The Great
Stock price: 0.013132530120481928
P/E ratio: 0.4473611252772024
Shares outstanding: 393281732
Book value: 111591000
P/B ratio: 0.046283160750645674
Market cap (USD): 5164784.191325301
Debt to equity: 0.0032887956914088054
Current ratio: 2.55355384918291
Quick ratio: 2.55355384918291
Effective tax rate (%): 27.727558066541118
Interest coverage ratio: 428.1463414634146
COGS to revenue (%): 32.683466308555175
SG&A to revenue (%): 36.85599178450115
Free cash flow (dilution-adjusted): -23577000
Buyback yield (%): 0
Retained earnings: 43910000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.46771464824475
FCF margin (%): -37.24938778734497
Rule of 40 score: -37.24938778734497
Financial ratios for TBLD.L — annual report dated 2023-12-31
Total revenue: 44663000
Gross profit: -22523000
Operating income: -49027000
Net income: -62537000
Capital expenditures: 180000
Operating cash flow: 10879000
Depreciation & amortization: 15919000
Net tangible assets: -3056000
Owner earnings: -46798000
Buffett classification: The Gruesome
Stock price: 0.0006329113924050633
Shares outstanding: 393281732
Book value: 48105000
P/B ratio: 0.005174357938002181
Market cap (USD): 248912.48860759495
Debt to equity: 0.0078578110383536
Current ratio: 0.7901656972481549
Quick ratio: 0.7901656972481549
Interest coverage ratio: -1225.675
COGS to revenue (%): 150.4287665405369
SG&A to revenue (%): 58.41524304233929
Free cash flow (dilution-adjusted): -21614000
Buyback yield (%): 414.2017966906228
Retained earnings: -18213000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -100.79771376878637
FCF margin (%): -48.39352484159147
Revenue growth (%): -29.4367643573742
Rule of 40 score: -77.83028919896567
Financial ratios for TBLD.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -2446000
Buffett classification: The Gruesome
Stock price: 0.0008750000000000001
Shares outstanding: 393281732
Book value: 38881000
P/B ratio: 0.008850634384403694
Market cap (USD): 344121.51550000004
Debt to equity: 0.009824850183894448
Current ratio: 0.7558370421088668
Quick ratio: 0.7558370421088668
Buyback yield (%): 0
Retained earnings: -38587000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TBLD.L — annual report dated 2024-12-31
Total revenue: 30438000
Gross profit: -1897000
Operating income: -19321000
Net income: -20522000
Capital expenditures: 22000
Operating cash flow: 6290000
Depreciation & amortization: 14415000
Net tangible assets: -2446000
Owner earnings: -6129000
Buffett classification: The Gruesome
Stock price: 0.0008750000000000001
Shares outstanding: 393281732
Book value: 38881000
P/B ratio: 0.008850634384403694
Market cap (USD): 344121.51550000004
Debt to equity: 0.009824850183894448
Current ratio: 0.7558370421088668
Quick ratio: 0.7558370421088668
Interest coverage ratio: -715.5925925925926
COGS to revenue (%): 106.23234115250672
SG&A to revenue (%): 56.757999868585316
Free cash flow (dilution-adjusted): -13195000
Buyback yield (%): 20.051056644843815
Retained earnings: -38587000
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.22171553766591
FCF margin (%): -43.35041724160589
Revenue growth (%): -31.84962944719343
Rule of 40 score: -75.20004668879932
Financial ratios for TBLD.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 1143000
Buffett classification: The Gruesome
Stock price: 0.000821917808219178
Shares outstanding: 393281732
Book value: 41785000
P/B ratio: 0.007735916218214243
Market cap (USD): 323245.25917808217
Debt to equity: 0.0027282517649874355
Current ratio: 1.0508912108174555
Quick ratio: 1.0508912108174555
Buyback yield (%): 0
Retained earnings: -35787000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNG.PA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 2.8863636363636362
Shares outstanding: 278255465
Market cap (USD): 803146455.7954545
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNG.PA — annual report dated 2022-12-31
Total revenue: 3689361.7021276597
Operating income: -31634042.55319149
Net income: -34897872.340425536
Capital expenditures: 1592553.1914893617
Operating cash flow: -21598936.170212768
Depreciation & amortization: 1793617.0212765958
Net tangible assets: 40174468.08510639
Owner earnings: -34696808.510638304
Return on net tangible assets (%): -86.36532147018326
Buffett classification: The Gruesome
Stock price: 1.7659574468085106
Shares outstanding: 278255465
Book value: 40256382.97872341
P/B ratio: 12.206444647340184
Market cap (USD): 491387310.5319149
Debt to equity: 0.06471816283924843
Current ratio: 3.638397746831482
Quick ratio: 3.638397746831482
Interest coverage ratio: -36.98507462686567
COGS to revenue (%): 0
R&D to revenue (%): 927.5663206459054
SG&A to revenue (%): 92.87773933102653
Free cash flow (dilution-adjusted): -26077659.574468087
Buyback yield (%): 0
Retained earnings: -88757446.80851065
Receivables turnover: 1.2434564359985658
Capitalized R&D asset: 34221276.595744684
ROCI (R&D-adjusted, %): -9.660304661586384
FCF margin (%): -706.8339100346021
Rule of 40 score: -706.8339100346021
Financial ratios for TNG.PA — annual report dated 2023-12-31
Total revenue: 1611111.111111111
Operating income: -31861111.111111112
Net income: -24808888.888888888
Capital expenditures: 2963333.3333333335
Operating cash flow: -38523333.333333336
Depreciation & amortization: 1746666.6666666665
Net tangible assets: 17257777.777777776
Owner earnings: -26025555.555555552
Return on net tangible assets (%): -150.8047901107391
Buffett classification: The Gruesome
Stock price: 1.5222222222222224
Shares outstanding: 278255465
Book value: 17346666.666666668
P/B ratio: 24.417754743146297
Market cap (USD): 423566652.2777778
Debt to equity: 0.08051498847040738
Current ratio: 1.7908783110934074
Quick ratio: 1.7908783110934074
Interest coverage ratio: -170.68452380952382
COGS to revenue (%): 0
R&D to revenue (%): 2040.5517241379312
SG&A to revenue (%): 263.3103448275862
Free cash flow (dilution-adjusted): -41896666.666666664
Buyback yield (%): 0
Retained earnings: -117511111.1111111
Receivables turnover: 1.8637532133676094
Capitalized R&D asset: 55803810.874704495
ROCI (R&D-adjusted, %): -22.50164282091124
FCF margin (%): -2600.4827586206898
Revenue growth (%): -56.33089837242087
Rule of 40 score: -2656.8136569931107
Financial ratios for TNG.PA — annual report dated 2024-12-31
Total revenue: 319791.6666666667
Operating income: -37172916.66666667
Net income: -35386458.333333336
Capital expenditures: 3193750
Operating cash flow: -24529166.666666668
Depreciation & amortization: 1334375
Net tangible assets: 15772916.666666668
Owner earnings: -37245833.333333336
Return on net tangible assets (%): -236.13789459780742
Buffett classification: The Gruesome
Stock price: 0.7083333333333334
Shares outstanding: 278255465
Book value: 15837500
P/B ratio: 12.44499580373586
Market cap (USD): 197097621.0416667
Debt to equity: 0.0011181268087345436
Current ratio: 1.477974828375286
Quick ratio: 1.477974828375286
Interest coverage ratio: -21.22903033908388
COGS to revenue (%): 0
R&D to revenue (%): 11165.472312703583
SG&A to revenue (%): 1189.902280130293
Free cash flow (dilution-adjusted): -28323958.333333336
Buyback yield (%): 0
Retained earnings: -145553125
Receivables turnover: 0.2588532883642496
Capitalized R&D asset: 69025893.49881797
ROCI (R&D-adjusted, %): -36.31892218396393
FCF margin (%): -8857.00325732899
Revenue growth (%): -80.15086206896551
Rule of 40 score: -8937.154119397956
Financial ratios for TNG.PA — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 15772916.666666668
Buffett classification: The Gruesome
Stock price: 0.7083333333333334
Shares outstanding: 278255465
Book value: 15837500
P/B ratio: 12.44499580373586
Market cap (USD): 197097621.0416667
Debt to equity: 0.0011181268087345436
Current ratio: 1.477974828375286
Quick ratio: 1.477974828375286
Buyback yield (%): 0
Retained earnings: -145553125
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TNG.PA — quarterly report dated 2025-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.717391304347826
Shares outstanding: 278255465
Market cap (USD): 199618050.97826087
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TWO — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 12.24
Shares outstanding: 105046333
Market cap (USD): 1285767115.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TWO — annual report dated 2022-12-31
Total revenue: 407180000
Net income: 220239000
Capital expenditures: 629810000
Operating cash flow: 623402000
Net tangible assets: -801412000
Owner earnings: -409571000
Buffett classification: The Gruesome
Stock price: 9.39
P/E ratio: 4.478702985710978
Shares outstanding: 105046333
Book value: 2183525000
P/B ratio: 0.4517397633963431
Market cap (USD): 986385066.87
Debt to equity: 0.8240519343721734
Effective tax rate (%): 32.11969721253067
COGS to revenue (%): 0
SG&A to revenue (%): 10.001227958151187
Free cash flow (dilution-adjusted): -18038000
Buyback yield (%): 5.211149451310022
Retained earnings: -3815625000
Receivables turnover: 1.407018853320064
Capitalized R&D asset: 0
FCF margin (%): -4.429981826219363
Rule of 40 score: -4.429981826219363